[{"address1": "Level 10", "address2": "Tower 11 Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "592000", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sing Ee Wong", "age": 43, "title": "Chairman, CEO & President", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cu Seng Kiu", "age": 34, "title": "Executive Director, CFO & Secretary", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gill  Christie", "age": 67, "title": "Director of Human Resources", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Grace  Kim", "title": "Investor Relations Executive", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.3375, "open": 0.3201, "dayLow": 0.3201, "dayHigh": 0.369, "regularMarketPreviousClose": 0.3375, "regularMarketOpen": 0.3201, "regularMarketDayLow": 0.3201, "regularMarketDayHigh": 0.369, "payoutRatio": 0.0, "beta": 0.247, "trailingPE": 0.11836805, "forwardPE": -0.17130654, "volume": 985176, "regularMarketVolume": 985176, "averageVolume": 1352924, "averageVolume10days": 6528090, "averageDailyVolume10Day": 6528090, "bid": 0.36, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 8099613, "fiftyTwoWeekLow": 0.25, "fiftyTwoWeekHigh": 39.84, "priceToSalesTrailing12Months": 578.54376, "fiftyDayAverage": 2.5318, "twoHundredDayAverage": 6.98575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4151642, "profitMargins": 0.0, "floatShares": 747237, "sharesOutstanding": 23759500, "sharesShort": 31977, "sharesShortPriorMonth": 168464, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0013, "heldPercentInsiders": 0.61492, "heldPercentInstitutions": 0.06637, "shortRatio": 0.17, "shortPercentOfFloat": 0.043899998, "impliedSharesOutstanding": 23759500, "bookValue": 0.236, "priceToBook": 1.4444915, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -8347000, "trailingEps": 2.88, "forwardEps": -1.99, "lastSplitFactor": "1:16", "lastSplitDate": 1747008000, "enterpriseToRevenue": 296.546, "enterpriseToEbitda": -0.327, "52WeekChange": -0.98719877, "SandP52WeekChange": 0.09544468, "lastDividendValue": 0.15, "lastDividendDate": 1745884800, "quoteType": "EQUITY", "currentPrice": 0.3409, "recommendationKey": "none", "totalCash": 3450000, "totalCashPerShare": 0.155, "ebitda": -12679500, "totalDebt": 9000, "quickRatio": 5.204, "currentRatio": 5.602, "totalRevenue": 14000, "debtToEquity": 0.294, "revenuePerShare": 0.001, "returnOnAssets": -1.6018, "returnOnEquity": -19.50234, "grossProfits": 14000, "freeCashflow": -11783125, "operatingCashflow": -10754000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -906.0714, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.00741, "regularMarketPrice": 0.3409, "marketState": "CLOSED", "shortName": "Cyclacel Pharmaceuticals, Inc.", "longName": "Cyclacel Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1750463269, "regularMarketTime": 1750449602, "exchange": "NCM", "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1079447400000, "postMarketChangePercent": 2.6107323, "postMarketPrice": 0.3498, "postMarketChange": 0.008899987, "regularMarketChange": 0.0034, "regularMarketDayRange": "0.3201 - 0.369", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1352924, "fiftyTwoWeekLowChange": 0.090900004, "fiftyTwoWeekLowChangePercent": 0.36360002, "fiftyTwoWeekRange": "0.25 - 39.84", "fiftyTwoWeekHighChange": -39.4991, "fiftyTwoWeekHighChangePercent": -0.9914433, "fiftyTwoWeekChangePercent": -98.71988, "dividendDate": 1746057600, "earningsTimestamp": 1747284600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 2.88, "epsForward": -1.99, "fiftyDayAverageChange": -2.1909, "fiftyDayAverageChangePercent": -0.86535275, "twoHundredDayAverageChange": -6.6448503, "twoHundredDayAverageChangePercent": -0.95120066, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-06-21"}]